Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells

BACKGROUND: Mesothelin is a 40-kDa glycoprotein that is highly overexpressed in various types of cancers, however molecular mechanism of mesothelin has not been well-known. Amatuximab is a chimeric monoclonal IgG1/k antibody targeting mesothelin. We recently demonstrated that the combine therapy of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Matsuzawa, Fumihiko, Kamachi, Hirofumi, Mizukami, Tatsuzo, Einama, Takahiro, Kawamata, Futoshi, Fujii, Yuki, Fukai, Moto, Kobayashi, Nozomi, Hatanaka, Yutaka, Taketomi, Akinobu
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7912898/
https://ncbi.nlm.nih.gov/pubmed/33637083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07722-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados